Skip to content
lidoflazine

Structure via PubChem · Public domain (PubChem)

EntityQ6543740· pop 5· linked from 471 articles

lidoflazine

Sign in to save

Lidoflazine is a piperazine calcium channel blocker. It is a coronary vasodilator with some antiarrhythmic action. Lidoflazine was discovered at Janssen Pharmaceutica in 1964. In 2025 Lidoflazine has also been reported to interact with tubulin and inhibit its polymerization.

Chemical data

Formula
C30H35F2N3O
Molecular weight
491.6 g/mol
IUPAC name
2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]-N-(2,6-dimethylphenyl)acetamide
SMILES
CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
InChIKey
ZBIAKUMOEKILTF-UHFFFAOYSA-N
XLogP
6
Polar surface area
35.6 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
cardiovascular disease

via ChEMBL · EBI

Wikidata facts

Mass
491.275
Show 3 more facts
chemical formula
C₃₀H₃₅F₂N₃O
canonical SMILES
CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
subject has role
calcium channel blocker
Sources (2)

via Wikidata · CC0

~2 min read

Encyclopedic overview

4 sections
Contents
  • Physical properties
  • Solubility at room temperature
  • References
  • Further reading

Lidoflazine is a piperazine calcium channel blocker. It is a coronary vasodilator with some antiarrhythmic action. Lidoflazine was discovered at Janssen Pharmaceutica in 1964. In 2025 Lidoflazine has also been reported to interact with tubulin and inhibit its polymerization.

==Physical properties== ===Solubility at room temperature===

Excerpted from Wikipedia’s “lidoflazine” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0